Microbial Sensitivity Tests
"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
| Descriptor ID |
D008826
|
| MeSH Number(s) |
E01.370.225.875.595 E05.200.875.595 E05.337.550.400
|
| Concept/Terms |
Microbial Sensitivity Tests- Microbial Sensitivity Tests
- Microbial Sensitivity Test
- Sensitivity Test, Microbial
- Sensitivity Tests, Microbial
- Test, Microbial Sensitivity
- Tests, Microbial Sensitivity
- Drug Sensitivity Assay, Microbial
Minimum Inhibitory Concentration- Minimum Inhibitory Concentration
- Concentration, Minimum Inhibitory
- Concentrations, Minimum Inhibitory
- Inhibitory Concentration, Minimum
- Inhibitory Concentrations, Minimum
- Minimum Inhibitory Concentrations
Bacterial Sensitivity Tests- Bacterial Sensitivity Tests
- Tests, Bacterial Sensitivity
- Sensitivity Tests, Bacterial
- Test, Bacterial Sensitivity
- Bacterial Sensitivity Test
- Sensitivity Test, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".
Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".
This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 5 | 7 |
| 1995 | 0 | 9 | 9 |
| 1996 | 2 | 11 | 13 |
| 1997 | 1 | 9 | 10 |
| 1998 | 0 | 7 | 7 |
| 1999 | 0 | 8 | 8 |
| 2000 | 0 | 11 | 11 |
| 2001 | 1 | 15 | 16 |
| 2002 | 0 | 16 | 16 |
| 2003 | 3 | 34 | 37 |
| 2004 | 1 | 18 | 19 |
| 2005 | 1 | 26 | 27 |
| 2006 | 0 | 28 | 28 |
| 2007 | 0 | 24 | 24 |
| 2008 | 0 | 20 | 20 |
| 2009 | 0 | 20 | 20 |
| 2010 | 0 | 27 | 27 |
| 2011 | 1 | 28 | 29 |
| 2012 | 1 | 22 | 23 |
| 2013 | 1 | 20 | 21 |
| 2014 | 2 | 21 | 23 |
| 2015 | 0 | 29 | 29 |
| 2016 | 0 | 23 | 23 |
| 2017 | 0 | 35 | 35 |
| 2018 | 1 | 14 | 15 |
| 2019 | 4 | 30 | 34 |
| 2020 | 1 | 27 | 28 |
| 2021 | 1 | 22 | 23 |
| 2022 | 1 | 25 | 26 |
| 2023 | 1 | 15 | 16 |
| 2024 | 9 | 8 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.
-
Synergistic effects of novel penicillin-binding protein 1A amino acid substitutions contribute to high-level amoxicillin resistance of Helicobacter pylori. mSphere. 2024 Aug 28; 9(8):e0008924.
-
Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response. Clin Infect Dis. 2024 Jul 19; 79(1):15-21.
-
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin. Antimicrob Agents Chemother. 2024 Aug 07; 68(8):e0012724.
-
Mutations Affecting Cellular Levels of Cobalamin (Vitamin B12) Confer Tolerance to Bactericidal Antibiotics in Burkholderia cenocepacia. J Microbiol Biotechnol. 2024 Aug 28; 34(8):1609-1616.
-
Rapid in vitro activity of telavancin against Bacillus anthracis and in vivo protection against inhalation anthrax infection in the rabbit model. Antimicrob Agents Chemother. 2024 Jul 09; 68(7):e0011224.
-
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's response. Clin Microbiol Infect. 2024 Sep; 30(9):1207-1208.
-
Evaluation of the presence of integrons, sul and smqnr genes and the prevalence of antibiotic resistance in Stenotrophomonas maltophilia clinical isolates. Indian J Med Microbiol. 2024 May-Jun; 49:100612.
-
Alternative iron-depleted media for cefiderocol susceptibility testing. Int J Antimicrob Agents. 2024 Jul; 64(1):107193.
-
Argyreia nervosa-driven biosynthesis of Cu-Ag bimetallic nanoparticles from plant leaves extract unveils enhanced antibacterial properties. Bioprocess Biosyst Eng. 2024 Aug; 47(8):1307-1319.
-
Comparison of cefiderocol in-vitro susceptibility testing modalities. J Glob Antimicrob Resist. 2024 Jun; 37:100-101.